Literature DB >> 10092764

Role for the Rac1 exchange factor Vav in the signaling pathways leading to NK cell cytotoxicity.

R Galandrini1, G Palmieri, M Piccoli, L Frati, A Santoni.   

Abstract

Here we investigate the activation of and a possible role for the hematopoietic Rac1 exchange factor, Vav, in the signaling mechanisms leading to NK cell-mediated cytotoxicity. Our data show that direct contact of NK cells with a panel of sensitive tumor targets leads to a rapid and transient tyrosine phosphorylation of Vav and to its association with tyrosine-phosphorylated Syk. Vav tyrosine phosphorylation is also observed following the activation of NK cells through the low-affinity Fc receptor for IgG (Fc gamma RIII). In addition, we demonstrate that both direct and Ab-mediated NK cell binding to target cells result in the activation of nucleotide exchange on endogenous Rac1. Furthermore, Vav antisense oligodeoxynucleotide treatment leads to an impairment of NK cytotoxicity, with Fc gamma RIII-mediated killing being more sensitive to the abrogation of Vav expression. These results provide new insight into the signaling pathways leading to cytotoxic effector function and define a role for Vav in the activation of NK cell-mediated killing.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10092764

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

Review 1.  Regulatory and signaling properties of the Vav family.

Authors:  X R Bustelo
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

2.  β2 integrin induces TCRζ-Syk-phospholipase C-γ phosphorylation and paxillin-dependent granule polarization in human NK cells.

Authors:  Michael E March; Eric O Long
Journal:  J Immunol       Date:  2011-01-26       Impact factor: 5.422

3.  Vav1 dephosphorylation by the tyrosine phosphatase SHP-1 as a mechanism for inhibition of cellular cytotoxicity.

Authors:  Christopher C Stebbins; Carsten Watzl; Daniel D Billadeau; Paul J Leibson; Deborah N Burshtyn; Eric O Long
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

4.  NKG2D gene polymorphisms are associated with disease control of chronic myeloid leukemia by dasatinib.

Authors:  Ryujiro Hara; Makoto Onizuka; Erika Matsusita; Eri Kikkawa; Yoshihiko Nakamura; Hiromichi Matsushita; Daisuke Ohgiya; Hiromichi Murayama; Shinichiro Machida; Ken Ohmachi; Yukari Shirasugi; Yoshiaki Ogawa; Hiroshi Kawada; Kiyoshi Ando
Journal:  Int J Hematol       Date:  2017-08-09       Impact factor: 2.490

Review 5.  Epigenetic regulation of natural killer cell memory.

Authors:  Colleen M Lau; Gabriela M Wiedemann; Joseph C Sun
Journal:  Immunol Rev       Date:  2021-12-14       Impact factor: 12.988

6.  Cereblon regulates NK cell cytotoxicity and migration via Rac1 activation.

Authors:  Cinzia Fionda; Helena Stabile; Rosa Molfetta; Andrea Kosta; Giovanna Peruzzi; Silvia Ruggeri; Alessandra Zingoni; Cristina Capuano; Alessandra Soriani; Rossella Paolini; Angela Gismondi; Marco Cippitelli; Angela Santoni
Journal:  Eur J Immunol       Date:  2021-09-18       Impact factor: 6.688

7.  Differently phosphorylated forms of the cortactin homolog HS1 mediate distinct functions in natural killer cells.

Authors:  Boyd Butler; Diana H Kastendieck; John A Cooper
Journal:  Nat Immunol       Date:  2008-06-29       Impact factor: 25.606

Review 8.  Syk and pTyr'd: Signaling through the B cell antigen receptor.

Authors:  Robert L Geahlen
Journal:  Biochim Biophys Acta       Date:  2009-03-21

9.  Inhibitory signaling blocks activating receptor clustering and induces cytoskeletal retraction in natural killer cells.

Authors:  Thushara P Abeyweera; Ernesto Merino; Morgan Huse
Journal:  J Cell Biol       Date:  2011-02-21       Impact factor: 10.539

10.  Activating Natural Killer Cell Receptors, Selectins, and Inhibitory Siglecs Recognize Ebolavirus Glycoprotein.

Authors:  Mostafa Jarahian; Katharina Marstaller; Nadine Banna; Roshanak Ahani; Mohammad Hossein Etemadzadeh; Lea K Boller; Kayhan Azadmanesh; Angel Cid-Arregui; Abdolrahman Khezri; Martin R Berger; Frank Momburg; Carsten Watzl
Journal:  J Innate Immun       Date:  2021-08-23       Impact factor: 7.111

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.